At booth #115, Integer will spotlight its latest advancements in neuromodulation and next-generation miniaturized active implantable medical devices (AIMDs). These innovations are designed to ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer ...

ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

This approval represents a significant regulatory milestone, making Proliv™Rx the first and only at-home neuromodulation ...

ImagineHealth and Vivatronix partner to bring SpineX’s neuromodulation technology to global markets, enhancing recovery for neurological condition patients. Patients have been waiting for a solution ...

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

POMONA, NEW YORK, UNITED STATES, January 31, 2024 /EINPresswire.com/ -- NeuroLight, Inc. today announced the recent grant of US Patent No. 11,413,425 for the ...

(BPT) - New precision neuromodulation techniques are redefining what's possible for neurological recovery, and the National Institutes of Health (NIH) has made a substantial investment to support the ...